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Edited by Robert BaroukiAbstract Knockdown or inhibition of SIRT2 enhances biologi-
cal stress-tolerance. We extend this phenotype showing that
SIRT2 knockdown reduces anoxia–reoxygenation injury in
H9c2 cells. Gene array analysis following SIRT2 siRNA knock-
down identiﬁes 14-3-3 f as the most robustly induced gene.
SIRT2 knockdown evokes induction of this chaperone, facilitat-
ing cytosolic sequestration of BAD with a corresponding reduc-
tion in mitochondrial BAD localization. Concurrent siRNA
against SIRT2 and 14-3-3 f abolishes the SIRT2-depleted cyto-
protective phenotype. SIRT2 functions to moderate cellular
stress-tolerance, in part, by modulating the levels of 14-3-3 f
with the concordant control of BAD subcellular localization.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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reoxygenation1. Introduction
Sirtuins, through NAD+-dependent deacetylation of target
proteins, generally augment stress-tolerance and lifespan
extension and are thought to function in part by augmenting
DNA-repair and anti-oxidant defenses [1]. The functions of
sirtuins have predominantly been explored in the context of
caloric restriction; however the ameliorative eﬀects of these
proteins have been explored in response to more robust biolog-
ical stressors including ischemic and oxidative stress in the
heart and cardiomyocytes. SIRT1 and SIRT7 attenuate oxida-
tive and genotoxic stress in cardiac myocytes [2,3], protect the
intact heart against oxidative stress [4] and prevent aging-asso-
ciated cardiac dysfunction [3].
In contrast, evidence is beginning to demonstrate that
SIRT2 functions as a negative regulator of biological stress
[5,6]. The mechanisms governing this regulation is beginning
to be explored [7]. To further explore this we investigated the
role of SIRT2 in cardiac-derived H9c2 cells. We show that
SIRT2 is induced by anoxia–reoxygenation, and that SIRT2
overexpression increased susceptibility to cell death via its
deacetylase activity. Conversely, SIRT2 siRNA enhances
anoxia–reoxygenation tolerance. As SIRT2 depletion enhances
oxidative stress-tolerance, we employed gene array proﬁling to
screen for putative adaptive candidate genes. We identiﬁed*Corresponding author. Fax: +1 301 402 0888.
E-mail address: sackm@nhlbi.nih.gov (M.N. Sack).
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doi:10.1016/j.febslet.2008.07.016adaptor protein 14-3-3 f as the most highly induced gene.
14-3-3 f protein was concordantly induced and associated with
the sequestration of BAD in the cytoplasm. Knockdown of
14-3-3 f prevents SIRT2 depletion-mediated anoxia–reoxygen-
ation tolerance. These results identify SIRT2 as a negative reg-
ulator moderating tolerance to anoxia–reoxygenation in H9c2
cells, in part, by modulating 14-3-3 f and identify BAD as a
cytosolic substrate of 14-3-3 f.2. Materials and methods
2.1. Cell culture and transfection
H9c2 rat cardiac-derived myoblasts (ATCC) were cultured in
DMEM containing 10% FBS, 1% penicillin/streptomycin at 37 C,
5% CO2. Cells transfected with negative control siRNA (Invitrogen),
SIRT2 siRNA (Dharmacon – Cat. No. M-08072-00), 14-3-3 f siRNA
(Qiagen – Cat. No. SI02055536), pcDNA3.1 plasmid (Invitrogen),
pcDNA-FLAG/HA-14-3-3 f (Addgene), pcDNA3.1-Myc/His-SIRT2
construct (Biochain) or with the deacetylase mutant SIRT2 construct
pcDNA-SIRT2 (N168A) [8] using a Nucleofector II Device (Amaxa)
were cultured for 48 h prior to experiments.2.2. Cell viability
Transfected cells were exposed to 17-h anoxia in DMEM media (no
glucose, pyruvate, or antibiotics), using a GasPak EZ system (Becton–
Dickenson). Following anoxia, fully constituted DMEM was added
and cells were incubated for an additional 2 h. Cellular injury was
determined using a LDH cell viability assay (CytoTox 96, Promega)
spectrophotometrically and conﬁrmed by measuring propidium iodine
(PI – BD Pharmingen) uptake using ﬂow cytometry (BD FACSCali-
bur).
2.3. RNA isolation and expression levels
H9c2 total RNA was prepared using a RNeasy RNA isolation kit
(Qiagen). RNA was quantiﬁed and used for gene array analyses and
RT-PCR. Ampliﬁcation of H9c2 RNA and gene array analysis was
performed using Rat Genome 230 2.0 Array (Aﬀymetrix) microarrays.
Real-time quantitative PCR was performed with SYBR Green PCR
Master Mix (Applied Biosystems) using a MJ Research DNA Engine
Opticon 2 ﬂuorescence detection system. Ribosomal 18s and Tbp1
primers were used as internal standards.
2.4. Protein analyses
Primary antibodies: rabbit 14-3-3 f (Santa Cruz); mouse actin
(Ambion); rabbit BAD (Cell Signaling); mouse VDAC (Invitrogen)
and rabbit aldose reductase (Santa Cruz). H9c2 cells were harvested
and lysed in RIPA buﬀer containing protease inhibitors. For BAD
localization experiments, cells were subfractionated using the Qprote-
ome Mitochondrial Isolation Kit (Qiagen). Brieﬂy, cells were centri-
fuged (1000 · g, 10 min, 4 C) and the cytosolic protein-containing
supernatant collected. The pellet was resuspended in Qiagen Disrup-
tion Buﬀer and then centrifuged (1000 · g, 10 min, 4 C) and the super-
natant transferred to a new tube. After additional centrifugation
(6000 · g, 10 min, 4 C) the pellet was washed and centrifuged atEuropean Biochemical Societies.
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and used for SDS–PAGE. For co-immunoprecipitation experiments
equal amounts of cell lysate protein were incubated for 1 h at 4 C with
primary antibody and immunoprecipitated with agarose overnight at
4 C. Samples were used for SDS–PAGE and Western immunoblot-
ting.
2.5. Immunoﬂuorescence confocal microscopy
Cells grown on glass slides were washed in PBS and ﬁxed with 4%
paraformaldehyde followed by permeabilization with 0.1% Triton X-
100. Samples were blocked with 4% normal goat serum and then incu-
bated with the rabbit polyclonal antibody to BAD (1:100) and mono-
clonal antibody to COXI (MitoSciences, 1:100) for 1 h followed by
incubation with Alexa Fluor 488 conjugated goat anti-rabbit IgG
and 594 conjugated goat anti-mouse IgG (1:250, Molecular Probes).Fig. 1. The eﬀect of SIRT2 modulation on cell viability. (A) Temporal
regulation of SIRT2 transcript levels in response to anoxia–reoxygen-
ation. (B) Cell viability as measured by LDH release is enhanced in
cells depleted of SIRT2 while SIRT2 overexpression results in
increased LDH release in response to anoxia and reoxygenation. (C)
SIRT2-depleted H9c2 exposed to 17 h anoxia–2 h reoxygenation and
stained with PI exhibit decreased dead cells as measured by FACS
analyses (n = 6 per group, P < 0.05, versus control or the scrambled
siRNA or empty vector transfected control cells, respectively).Nuclei were counterstained with 4 06 0-diamidino-2 phenylindole
(DAPI, Molecular Probes). The images were collected using a Zeiss
LSM 510 confocal microscope.
2.6. Statistical analysis
Gene array expression levels were analyzed after segregation to ex-
clude gene probesets employing a false discovery rate (FDR) of
<20% and a fold change >1.2. Diﬀerences between groups were evalu-
ated for signiﬁcance using the Student t-test. Analyses to assess cell
death were evaluated for signiﬁcance using ANOVA. P < 0.05 was
considered statistically signiﬁcant, and data are expressed as mean ± -
S.E.M.3. Results
3.1. Anoxia–reoxygenation stress-tolerance in response to
modulation of SIRT2
In keeping with a detrimental regulatory role of SIRT2 in re-
sponse to biological stress we ﬁnd a temporal induction ofFig. 2. Conﬁrmation of gene and protein levels of 14-3-3 f. (A) RT-
PCR conﬁrms the induction of the gene encoding for 14-3-3 f in cells
transfected with SIRT2 siRNA versus scrambled control siRNA. (B)
SIRT2-depleted H9c2 exhibit increased 14-3-3 f protein levels
compared to controls, as measured by Western immunoblotting
(n = 4 per group, P < 0.05 versus their respective controls).
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(Fig. 1A). To functionally explore whether SIRT2 modulation
alters stress-tolerance we utilized anoxia–reoxygenation stress
in H9c2 cells as previously described [9]. Transient overexpres-
sion of SIRT2 resulted in an eight-fold increase in SIRT2 gene
expression and conversely the mRNA levels of SIRT2 were
blunted in excess of 75 ± 3% following siRNA transfection
(Suppl. Fig. 1A and B). SIRT2 overexpression and gene deple-
tion did not alter basal cell viability with normoxia (Fig. 1B).
In contrast, the induction of SIRT2 enhanced cellular damage
in response to 17 h of anoxia and reoxygenation and the genet-
ic depletion of SIRT2 enhanced H9c2 viability, as measured by
cellular LDH release following reoxygenation. Interestingly,
the overexpression of a deacetylase mutant SIRT2 construct
enhanced tolerance above that achieved with the empty vector.Fig. 3. 14-3-3 f and BAD protein interactions in response to SIRT2 deplet
quantiﬁed by densitometry (n = 4 per group, P < 0.05 versus scrambled siRNA
protein associated with 14-3-3 f relative to controls. 14-3-3 f protein was imm
by Western immunoblotting. (B) SIRT2-depleted H9c2 show increased 14-3-3
immunoprecipitated from cell lysates and associated 14-3-3 f protein detecte
and (D) BAD show increased interaction with the reciprocal protein follo
interaction in cells overexpressing SIRT2.To conﬁrm this ameliorative phenotype in response to the
reduction in SIRT2 we assessed the cellular uptake of propidi-
um iodide comparing cells with basal and diminished SIRT2
levels. In parallel with the LDH release assay, a greater pro-
portion of SIRT2 siRNA-treated cells were viable in response
to anoxia–reoxygenation injury compared to controls (Fig.
1C).
3.2. Gene proﬁling identiﬁes 14-3-3 f upregulation following
SIRT2 siRNA
As the knockdown of SIRT2 enhances tolerance to anoxia–
reoxygenation cell death we employed gene proﬁling analysis
to identify putative targets that modulate this stress-tolerance
following the reduction in SIRT2 levels. Only 39 genes exhib-
ited diﬀerences using an FDR of 20% with a fold change of 1.2ion. H9c2 were transfected with SIRT2 siRNA for 48 h. Results were
transfected controls). (A) SIRT2-depleted H9c2 show increased BAD
unoprecipitated from cell lysates and associated BAD protein detected
f protein associated with BAD, relative to controls. BAD protein was
d by Western immunoblotting. Immunoprecipitation with (C) 14-3-3 f
wing 14 h of anoxia in SIRT2 siRNA cells and a diminution in this
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the most robustly downregulated gene in SIRT2 siRNA trea-
ted cells was the gene set encoding SIRT2. The most highly in-
duced transcript encoded for the adaptor protein 14-3-3 f
(Suppl. Table 1). The induction of this gene was conﬁrmed
using RT-PCR (Fig. 2A). To further evaluate the relationship
between SIRT2 and 14-3-3 f, the gene levels of 14-3-3 f was as-
sessed in response to SIRT2 overexpression. Here, 14-3-3 f
transcript levels were diminished 48 ± 5% (P = 0.04) relative
to empty vector controls (data not shown). We then conﬁrmed
that this gene regulatory event was mirrored at the protein le-
vel with the upregulation of the 14-3-3 f protein by 50 ± 4% in
SIRT2 siRNA-treated cells versus control cells (Fig. 2B).
3.3. SIRT2 knockdown-induced upregulation of 14-3-3 f
enhances interaction with BAD
Interestingly, a 14-3-3 binding site consensus region has been
previously shown to associate with and to sequester BAD in
the cytosol thereby promoting cell survival [10]. As 14-3-3 f
protein levels were enriched in response to SIRT2 depletion
we next determined whether the interaction between the 14-
3-3 f isoform and BAD was increased in cells with reduced
SIRT2. SIRT2 knockdown did not modulate the steady state
level of BAD (Fig. 2B) but evoked an increased and reciprocal
interaction between 14-3-3 f and BAD proteins compared to
control cells (Fig. 3A and B). To conﬁrm that this mechanism
is operational in response to anoxia–reoxygenation, we show
that following anoxia the interaction between 14-3-3 f and
BAD is enhanced in SIRT2 siRNA cells and diminished in
SIRT2 over-expressing cells (Fig. 3C and D).
3.4. 14-3-3 f siRNA abolishes SIRT2 knockdown anoxia–
reoxygenation resilience
Concurrent SIRT2 and 14-3-3 f siRNA completely nulliﬁes
the cytoprotection of SIRT2 knockdown alone (Fig. 4). The
pivotal role of 14-3-3 f in cytosolic sequestration of pro-apop-
totic factors is further demonstrated in that 14-3-3 f siRNAFig. 4. SIRT2 and 14-3-3 f levels modulate anoxia–reoxygenation
tolerance. Cell viability as measured by LDH release is diminished in
cells depleted of 14-3-3 f and conversely enhanced by the overexpres-
sion of 14-3-3 f. The knockdown of 14-3-3 f in parallel with SIRT2
abolishes the protection conferred by SIRT2 siRNA alone (n = 3 per
group, P < 0.05, * – versus the scrambled siRNA or empty vector
transfected control cells, # – versus SIRT2 siRNA and  – versus
pcDNA14-3-3 f, respectively).administration exacerbates anoxia–reoxygenation injury to a
similar degree to the overexpression of SIRT2 and in that
14-3-3 f overexpression is cytoprotective independent of
SIRT2 levels (Fig. 4).
3.5. Modulation of SIRT2 determines the intracellular
distribution of BAD
We hypothesized that modulating SIRT2 expression would
modify the relative localization of BAD to the cytosol or mito-
chondria in parallel with 14-3-3 f expression. Using confocal
microcopy and immunoﬂuorescent antibodies directed against
both BAD and a mitochondrial protein, cytochrome c oxidase
I (COXI), we demonstrate diminished mitochondrial localiza-
tion of BAD following SIRT2 knockdown and mitochondrial
enrichment of BAD following SIRT2 over-expression (Fig.
5A). This phenotype is also operational following anoxia as
shown by the subcellular localization immunoblot analysis
comparing cytosolic to mitochondrial extracts (Fig. 5B and C).4. Discussion
Using anoxia–reoxygenation as a biological stressor this
study expands the repertoire of stresses that is alleviated by
SIRT2 depletion. We demonstrate that 14-3-3 f is induced in
response to SIRT2 depletion and mediates SIRT2-dependent
modulation of stress-tolerance in H9c2 cells. 14-3-3 f is more-
over shown to directly interact with BAD with a parallel
reduction in mitochondrial BAD localization. The functional
consequence of SIRT2 depletion in enhancing tolerance to re-
dox injury is further supported by the protective eﬀect of over-
expression of the deacetylase mutant form of SIRT2 and by
the deleterious consequences of anoxia–reoxygenation follow-
ing overexpression of wildtype SIRT2.
The sirtuin family of NAD+-dependent deacetylases are pro-
posed to function through distinct targets to enhance DNA-re-
pair and anti-oxidant defenses [1]. The most robustly
characterized family member, SIRT1 has not only been shown
to enhance resilience to redox stress in cardiomyocytes and the
heart [2,4] but has also been shown to be necessary to maintain
basal cardiomyocyte viability [2]. The modulation in expres-
sion of SIRT2 in contrast does not alter basal H9c2 myoblast
cell viability. However, the SIRT2 transcript is induced by an-
oxia–reoxygenation stress and its genetic knockdown is cyto-
protective against anoxia–reoxygenation injury. These data
are consistent with SIRT2 depletion-mediated protection
against hydrogen peroxide, staurosporin and puromycin med-
iated cell death [5,7], and where SIRT2 knockdown and inhibi-
tion diminish dopaminergic-mediated cell death in a
drosophila model of Parkinsons disease [6]. Collectively, these
studies implicate that SIRT2 functions as a negative regulator
in response to diverse cellular stressors.
The biological targets of SIRT2 action are actively being ex-
plored and characterized [11,7,12]. Using gene array analysis
and conﬁrmatory RT-PCR, we identiﬁed that 14-3-3 f is inver-
sely regulated by the levels of SIRT2. 14-3-3 proteins are a
family of conserved regulatory phosphoserine-binding mole-
cules which are broadly expressed. By virtue of its interactions
with eﬀector proteins, 14-3-3 can modulate diverse biological
pathways including those regulating programmed cell death
[13]. BAD heterodimerizes with either BCL-XL or BCL-2 at
Fig. 5. Modulation of BAD subcellular localization with varying expression of SIRT2. (A) SIRT2 siRNA-treated (left column), control siRNA-
treated (middle column) and pSIRT2-transfected H9c2 cells (right column) were stained with anti-COXI (red) and anti-BAD (green) antibodies. The
lower panels are merged images. DAPI staining (blue) is used to visualize nuclei. Scale bar, 10 lm. Subcellular fractionation for western blot analysis
show reduced BAD in the mitochondrial fraction (B) and increased cytosolic levels (C) following SIRT2 siRNA and the reciprocal localization
following SIRT2 overexpression. VDAC – (voltage dependent anion channel – mitochondrial enriched) and ADR – (aldose reductase is cytosolic)
(n = 3 per group, P < 0.05 versus scrambled siRNA and empty vector controls).
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ities. 14-3-3 has been shown to bind pro-apoptotic BAD in a
phosphoserine-dependent manner resulting in the sequestra-
tion of BAD in the cytosol and inhibition of cell death [14].
The anti-apoptotic role of 14-3-3 f has been shown with
knockdown or dominant negative overexpression of this chap-
erone [13,15]. Our study demonstrates an increased interaction
of 14-3-3 f and BAD, diminished BAD localization to the
mitochondria as well as an increased number of viable cells
in response to anoxia–reoxygenation in cells depleted of
SIRT2. Whether SIRT2 depletion results in increased BAD
serine phosphorylation requires further investigation.
In conclusion, our data support a negative regulatory eﬀect
of SIRT2 on tolerance to anoxia–reoxygenation. Furthermore,
SIRT2 downregulation promotes 14-3-3 f induction, the cyto-
solic sequestration of BAD and the attenuation of anoxia–
reoxygenation induced cell death. These results identify a neg-
ative regulatory program that may be pharmacologically mod-
ulated by the novel SIRT2 inhibitor [6] as a potential cell
survival promoting strategy in enhancing tolerance to anox-
ia–reoxygenation injury.
Acknowledgements:We thank Nalini Raghavachari and Xiuli Xu from
the NHLBI Genomics Core for assistance with the gene array experi-
ments and analyses, Dr. Christian A Combs for assistance with confo-
cal microscopy and J. Philip McCoy Jr. from the NHLBI Flow
Cytometry Core for assistance. This work was supported by funding
from the Division of Intramural Research of the NHLBI of the Na-
tional Institutes of Health.Appendix A. Supplementary material
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.
2008.07.016.
References
[1] Haigis, M.C. and Guarente, L.P. (2006) Mammalian sirtuins –
emerging roles in physiology, aging, and calorie restriction. Genes
Dev. 20, 2913–2921.[2] Alcendor, R.R., Kirshenbaum, L.A., Imai, S., Vatner, S.F. and
Sadoshima, J. (2004) Silent information regulator 2alpha, a
longevity factor and class III histone deacetylase, is an essential
endogenous apoptosis inhibitor in cardiac myocytes. Circ. Res.
95, 971–980.
[3] Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger,
T., Kubin, T., Braun, T. and Bober, E. (2008) Sirt7 increases
stress resistance of cardiomyocytes and prevents apoptosis and
inﬂammatory cardiomyopathy in mice. Circ. Res.
[4] Alcendor, R.R. et al. (2007) Sirt1 regulates aging and resistance
to oxidative stress in the heart. Circ. Res. 100, 1512–1521.
[5] Grubisha, O., Rafty, L.A., Takanishi, C.L., Xu, X., Tong, L.,
Perraud, A.L., Scharenberg, A.M. and Denu, J.M. (2006)
Metabolite of SIR2 reaction modulates TRPM2 ion channel. J.
Biol. Chem. 281, 14057–14065.
[6] Outeiro, T.F. et al. (2007) Sirtuin 2 inhibitors rescue alpha-
synuclein-mediated toxicity in models of Parkinsons disease.
Science 317, 516–519.
[7] Wang, F., Nguyen, M., Qin, F.X. and Tong, Q. (2007) SIRT2
deacetylates FOXO3a in response to oxidative stress and caloric
restriction. Aging Cell 6, 505–514.
[8] Finnin, M.S., Donigian, J.R. and Pavletich, N.P. (2001)
Structure of the histone deacetylase SIRT2. Nat. Struct. Biol.
8, 621–625.
[9] McLeod, C.J., Aziz, A., Hoyt Jr., R.F., McCoy Jr., J.P. and Sack,
M.N. (2005) Uncoupling proteins 2 and 3 function in concert to
augment tolerance to cardiac ischemia. J. Biol. Chem. 280, 33470–
33476.
[10] Zha, J., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S.J.
(1996) Serine phosphorylation of death agonist BAD in response
to survival factor results in binding to 14-3-3 not BCL-X(L). Cell
87, 619–628.
[11] North, B.J., Marshall, B.L., Borra, M.T., Denu, J.M. and Verdin,
E. (2003) The human Sir2 ortholog, SIRT2, is an NAD+-
dependent tubulin deacetylase. Mol. Cell 11, 437–444.
[12] Vaquero, A. et al. (2006) SirT2 is a histone deacetylase with
preference for histone H4 Lys 16 during mitosis. Genes Dev. 20,
1256–12561.
[13] Xing, H., Zhang, S., Weinheimer, C., Kovacs, A. and Muslin,
A.J. (2000) 14-3-3 proteins block apoptosis and diﬀerentially
regulate MAPK cascades. EMBO J. 19, 349–358.
[14] Yang, X., Luo, C., Cai, J., Pierce, W. and Tezel, G. (2008)
Phosphorylation-dependent interaction with 14-3-3 regulates
Bad traﬃcking in retinal ganglion cells. Invest. Ophthalmol.
Vis. Sci.
[15] Niemantsverdriet, M., Wagner, K., Visser, M. and Backendorf,
C. (2008) Cellular functions of 14-3-3 zeta in apoptosis and cell
adhesion emphasize its oncogenic character. Oncogene 27, 1315–
1319.
